|
|
||||||||
Eur J Cardiothorac Surg 2005;28:838-843
© 2005 Elsevier Science NL
a Department of Cardiovascular Surgery, Inselspital, University Hospital, Freiburgstrasse, 3010 Berne, Switzerland
b Mayo Clinic, Rochester, MN, USA
c University of British Columbia, Vancouver, BC, Canada
d University of Pittsburgh, Epidemiology Data Coordinating Center, Pittsburgh, PA, USA
e University of Utah, Salt Lake City, UT, USA
Received 19 November 2004; received in revised form 2 September 2005; accepted 5 September 2005.
* Corresponding author. Tel.: +41 31 632 2375; fax: +41 31 632 4443. (Email: lars.englberger{at}insel.ch).
Objective: To examine risk factors for major paravalvular leak (PVL) events after mechanical heart valve replacement. Methods: We analyzed outcome of 807 patients randomized into the Artificial Valve Endocarditis Reduction Trial (AVERT). The mean follow-up time was 30.6 months and 21 major PVL events were reported. Three additional major PVL events associated with endocarditis were excluded from analysis. All baseline medical history variables, as well as operative parameters (including use of pledgets and suture technique) were examined using Cox regression. Results: Major PVL was reported after 11 aortic, 9 mitral, and 1 double valve replacement. 6/404 (1.5%) patients with conventional valves experienced a major PVL event versus 15/403 (3.7%) in the Silzone group. 10/172 (5.8%) patients with valve suture technique without pledgets experienced a major PVL event versus 11/635 (1.7%) patients with pledgets. Final multivariable model showed that only suture technique without pledgets (p = 0.005) was an independent significant risk factor for major PVL events. Silzone cuff showed a strong trend (p = 0.055). Conclusions: Suture technique without pledgets is an independent significant risk factor for major PVL events. In this study, use of pledgets during valve replacement had a protective effect against subsequent paravalvular leak, supporting the use of buttress reinforcement for valve suture. The use of Silzone cuff, although not statistically significant, showed a strong trend as a risk factor.
Key Words: Valve surgery Paravalvular leak Prosthetic valve endocarditis Risk factors
This article has been cited by other articles:
![]() |
W.R. E. Jamieson, G. J. Fradet, J. G. Abel, M. T. Janusz, S. V. Lichtenstein, J. S. MacNab, E. A. Stanford, and F. Chan Seven-year results with the St Jude Medical Silzone mechanical prosthesis. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1109 - 15.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Farhat, M. Durand, F. Delahaye, and O. Jegaden Prosthetic valve sewing-ring sealing with antibiotic and fibrin glue in infective endocarditis. A prospective clinical study Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 16 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Antunes Editorial comment: How much can we do to reach the ideal valve prosthesis? Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 843 - 844. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |